Cardiac resynchronisation therapy (CRT) is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles. CRT defibrillators (CRT-D) also incorporate the additional function of an implantable cardioverter-defibrillator (ICD), to quickly terminate an abnormally fast, life-threatening heart rhythm. CRT and CRT-D have become increasingly important therapeutic options for patients with moderate and severe heart failure.

Market Analysis and Insights: Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market
In 2020, the global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Scope and Market Size
The global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Implantable Cardioverter Defibrillator
External Defibrillator (ED)

Segment by Application
Hospitals
Ambulatory Surgery Centers

By Company
Medtronic
Abbott
Boston Scientific
MicroPort Scientific
BIOTRONIK
Medico
LivaNova

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE